Publisher
Springer Science and Business Media LLC
Subject
Law,Clinical Biochemistry,Spectroscopy,Sociology and Political Science,Social Sciences (miscellaneous),Clinical Psychology,Biochemistry
Reference32 articles.
1. Bakthavatchalam YD, Pragasam AK, Biswas I, Veeraraghavan B (2018) Polymyxin susceptibility testing, interpretative breakpoints, and resistance mechanisms: An update. J Glob Antimicrob Resist 12:124–136
2. Quintanilha JC, da Costa Duarte N, Lloret GR, Visacri MB, Mattos KP, Dragosavac D, Falcão AL, Moriel P (2019) Colistin and polymyxin B for treatment of nosocomial infections in intensive care unit patients: pharmacoeconomic analysis. Int J Clin Pharm 41:74–80
3. Brown P, Dawson MJ (2017) Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections. J Antibiot (Tokyo) 70:386–394
4. Ngamprasertchai T, Boonyasiri A, Charoenpong L, Nimitvilai S, Lorchirachoonkul N, Wattanamongkonsil L, Thamlikitkul V (2018) Effectiveness and safety of polymyxin B for the treatment of infections caused by extensively drug-resistant gram-negative bacteria in Thailand. Infect Drug Resist 11:1219–1224
5. Pan S, Huang X, Wang Y, Li L, Zhao C, Yao Z, Cui W, Zhang G (2018) Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR Acinectobacter baumannii: A retrospective cohort study, Antimicrob. Resist. Infect Control 7:1–9
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献